{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:13:12Z","timestamp":1795065192870,"version":"4.10.2"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2025.126823","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T11:26:49Z","timestamp":1742470009000},"page":"126823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Challenges and enablers to establishing COVID-19 vaccine effectiveness studies in the World Health Organization Africa region: A mixed-methods evaluation of the African region monitoring vaccine effectiveness (AFRO-MoVE) network"],"prefix":"10.1016","volume":"77","author":[{"given":"Adam W.","family":"Crawley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Plumb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Adjoa","family":"Ocansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Baffoe-Nyarko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Nyazema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibongile","family":"Walaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Leidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126823_bb0005","doi-asserted-by":"crossref","first-page":"e1099","DOI":"10.1016\/S2214-109X(22)00233-9","article-title":"COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns","volume":"10","author":"Cabore","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.126823_bb0010","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(22)01585-9","article-title":"The lancet commission on lessons for the future from the COVID-19 pandemic","volume":"400","author":"Sachs","year":"2022","journal-title":"Lancet London England"},{"key":"10.1016\/j.vaccine.2025.126823_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15585\/mmwr.mm7314a3","article-title":"COVID-19 vaccination coverage - World Health Organization African region, 2021-2023","volume":"73","author":"Doshi","year":"2024","journal-title":"MMWR Morb Mortal Weekly Report"},{"key":"10.1016\/j.vaccine.2025.126823_bb0020","series-title":"First COVID-19 COVAX vaccine doses administered in Africa","year":"2021"},{"key":"10.1016\/j.vaccine.2025.126823_bb0025","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.vaccine.2021.05.099","article-title":"Evaluation of post-introduction COVID-19 vaccine effectiveness: summary of interim guidance of the World Health Organization","volume":"39","author":"Patel","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126823_bb0030","series-title":"Evaluation of COVID-19 vaccine effectiveness [interim guidance]","year":"2021"},{"key":"10.1016\/j.vaccine.2025.126823_bb0035","article-title":"Covid-19 vaccine effectiveness against Sars-Cov-2-confirmed hospitalization in six countries and areas in the who European region: results from the first two years of the European severe acute respiratory infection vaccine effectiveness (Eurosave)","author":"Katz","year":"2024","journal-title":"Network"},{"key":"10.1016\/j.vaccine.2025.126823_bb0040","article-title":"Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021\u20132022: a test-negative case-control design","volume":"27","author":"Nogareda","year":"2023","journal-title":"Lancet Reg Health - Americas"},{"key":"10.1016\/j.vaccine.2025.126823_bb0050","author":"AFRO MOVE Network"},{"key":"10.1016\/j.vaccine.2025.126823_bb0055","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.amepre.2008.03.008","article-title":"Overview of formative, process, and outcome evaluation methods used in the VERB\u2122 campaign","volume":"34","author":"Berkowitz","year":"2008","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2025.126823_bb0060","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126823_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/irv.12915","article-title":"Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic","volume":"16","author":"Bergeri","year":"2022","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2025.126823_bb0070","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2214-109X(23)00165-1","article-title":"Prioritising respiratory syncytial virus prevention in low-income and middle-income countries","volume":"11","author":"Carbonell-Estrany","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.126823_bb0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/vaccines11040873","article-title":"Factors influencing the intention and uptake of COVID-19 vaccines on the African continent: a scoping review","volume":"11","author":"Naidoo","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.126823_bb0080","article-title":"Hypothesis testing and sample size considerations for the test-negative design","author":"Huo","year":"2024","journal-title":"Research Square [Preprint]."},{"key":"10.1016\/j.vaccine.2025.126823_bb0085","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2202061","article-title":"Effectiveness of Ad26.COV2.S and BNT162b2 vaccines against omicron variant in South Africa","author":"Gray","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.126823_bb0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(22)00007-1","article-title":"Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study","volume":"399","author":"Bekker","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2025.126823_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306309","article-title":"Efficacy and effectiveness of COVID-19 vaccines in Africa: a systematic review","volume":"19","author":"Raji","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.126823_bb0100","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3390\/vaccines12121415","article-title":"Seasonal influenza vaccination programs in the Americas: a platform for sustainable life-course immunization and its role for pandemic preparedness and response","volume":"12","author":"Nogareda","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.126823_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100097","article-title":"Seasonal influenza vaccination policies in the 194 WHO member states: the evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access","volume":"8","author":"Morales","year":"2021","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2025.126823_bb0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/EDE.0000000000001366","article-title":"Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines","volume":"32","author":"Lewnard","year":"2021","journal-title":"Epidemiol Cambridge MA"},{"key":"10.1016\/j.vaccine.2025.126823_bb0115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet London England"},{"key":"10.1016\/j.vaccine.2025.126823_bb0120","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/s41591-022-02054-0","article-title":"Data-enabled responses to pandemics: policy lessons from COVID-19","volume":"28","author":"Dhami","year":"2022","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:31:55Z","timestamp":1779913915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"alternative-id":["S0264410X25001203"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126823","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and enablers to establishing COVID-19 vaccine effectiveness studies in the World Health Organization Africa region: A mixed-methods evaluation of the African region monitoring vaccine effectiveness (AFRO-MoVE) network","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126823"}}